文章名稱引用次數(shù)

• Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis17
• Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies16
• Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia13
• Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the Food and Drug Administration database and review13
• Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts12
• Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation11
• The socioeconomic burden of patients affected by hemophilia with inhibitors11
• Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival11
• Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression11
• Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis11